Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.17B |
| 2 |
Microsoft
MSFT
|
+$619M |
| 3 |
Apple
AAPL
|
+$377M |
| 4 |
Booking.com
BKNG
|
+$319M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.48B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$896M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$599M |
| 4 |
Citigroup
C
|
+$467M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.29% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.55% |
| 4 | Financials | 1.15% |
| 5 | Healthcare | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11301
CALL
Genasys
GNSS
$66M
| $51.8K | ﹤0.01% |
+14,000
| New | +$40.5K |
|
|
WEJO
11302
DELISTED
Wejo Group Limited Common Shares
WEJO
| $51.8K | ﹤0.01% |
107,604
+61,343
| +133% | +$55K |
|
|
TKAT
11303
DELISTED
Takung Art Co., Ltd.
TKAT
| $51.7K | ﹤0.01% |
+93,961
| New | +$71.2K |
|
11304
Good Times Restaurants
GTIM
$15.8M
| $51.7K | ﹤0.01% |
23,176
-9,741
| -30% | -$23.2K |
|
11305
POET Technologies
POET
$1.3B
| $51.6K | ﹤0.01% |
+17,309
| New | +$49.4K |
|
|
CCLP
11306
DELISTED
CSI Compressco LP
CCLP
| $51.5K | ﹤0.01% |
38,714
-47,301
| -55% | -$60.5K |
|
|
TUYA
11307
Tuya Inc
TUYA
$1.15B
| $51.4K | ﹤0.01% |
26,933
+15,963
| +146% | +$19.4K |
|
|
PHX
11308
PUT
DELISTED
PHX Minerals
PHX
| $51.3K | ﹤0.01% |
13,200
-3,400
| -20% | -$12.8K |
|
11309
Biomerica
BMRA
$6.61M
| $51.3K | ﹤0.01% |
1,916
-8,664
| -82% | -$249K |
|
11310
Achieve Life Sciences
ACHV
$834M
| $51.3K | ﹤0.01% |
20,755
-8,522
| -29% | -$21.9K |
|
11311
PUT
Lexicon Pharmaceuticals
LXRX
$1.02B
| $51.2K | ﹤0.01% |
26,800
+4,500
| +20% | +$9.58K |
|
11312
CALL
Genprex
GNPX
$3.01M
| $51K | ﹤0.01% |
1
| – | – |
|
11313
Atossa Therapeutics
ATOS
$25.7M
| $51K | ﹤0.01% |
+6,433
| New | +$73.9K |
|
|
KC
11314
PUT
Kingsoft Cloud Holdings
KC
$3.19B
| $50.9K | ﹤0.01% |
13,300
-18,500
| -58% | -$53.1K |
|
|
PTN
11315
CALL
Palatin Technologies
PTN
$18.6M
| $50.7K | ﹤0.01% |
+396
| New | +$85.2K |
|
11316
Standard BioTools
LAB
$252M
| $50.5K | ﹤0.01% |
+43,137
| New | +$53.1K |
|
11317
PUT
LifeMD
LFMD
$151M
| $50.4K | ﹤0.01% |
26,000
-200
| -0.8% | -$448 |
|
|
AVYA
11318
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $50.2K | ﹤0.01% |
256,352
-32,430
| -11% | -$36.3K |
|
|
IDEX
11319
CALL
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $50K | ﹤0.01% |
2,502
-4,381
| -64% | -$127K |
|
11320
CALL
Recon Technology
RCON
$725K
| $49.9K | ﹤0.01% |
11
+1
| +10% | +$3.54K |
|
|
INFI
11321
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $49.8K | ﹤0.01% |
89,000
-75,500
| -46% | -$64.2K |
|
|
SLAI
11322
CALL
DELISTED
SOLAI Ltd ADS
SLAI
| $49.8K | ﹤0.01% |
4,500
+4,049
| +898% | +$62.9K |
|
|
BHIL
11323
PUT
DELISTED
Benson Hill, Inc.
BHIL
| $49.7K | ﹤0.01% |
+557
| New | +$54.5K |
|
|
IPHA
11324
Innate Pharma
IPHA
$248M
| $49.7K | ﹤0.01% |
+13,315
| New | +$30.3K |
|
11325
ZK International Group
ZKIN
$71.6M
| $49.6K | ﹤0.01% |
18,192
+15,351
| +540% | +$67.8K |
|
Similar funds
Jeff Yass's Q4 2022 Portfolio in Review
As of Q4 2022, Jeff Yass held 14,748 positions worth $395B, up 2.2% from $387B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q4 2022 filing shows 1,670 new, 4,598 increased, 5,764 reduced and 2,486 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M. The largest sale was Amazon, an estimated $1.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2022 buy was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M.
- Jeff Yass added most to Tesla in Q4 2022, an estimated $2.17B increase.
- Jeff Yass's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.48B.
- Jeff Yass fully exited Twitter, Inc. in Q4 2022, selling an estimated $76M.
- Jeff Yass's ten largest holdings make up 27% of its $395B portfolio in Q4 2022.
- Jeff Yass opened 1,670 new positions and closed 2,486 in Q4 2022.
- Jeff Yass's portfolio value rose 2.2% quarter-over-quarter to $395B.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.